NCT02966184 is a Phase 4 clinical trial of preservative free albuterol in Status Asthmaticus, sponsored by Norton Healthcare.

Who is sponsoring NCT02966184?

NCT02966184 is sponsored by Norton Healthcare.

What drugs are being tested in NCT02966184?

Interventions in NCT02966184: preservative free albuterol.

What condition does NCT02966184 study?

NCT02966184 studies Status Asthmaticus.

Is NCT02966184 still recruiting?

NCT02966184 is currently terminated. Last updated 20 May 2021.

Are results published for NCT02966184?

Yes — primary outcome results have been posted to ClinicalTrials.gov. See the outcomes section above for details.

Last reviewed 2021-05-20 · How we verify

NCT02966184

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Comparison of Albuterol for Status Asthmaticus

Terminated Phase 4 Results posted Last updated 20 May 2021

What this trial tests

Phase 4 trial testing preservative free albuterol in Status Asthmaticus in 8 participants. Terminated before completion.

Timeline

10 September 2018

Primary endpoint
25 October 2018

25 October 2018

Quick facts

Lead sponsor	Norton Healthcare
Phase	Phase 4
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	8
Start date	10 September 2018
Primary completion	25 October 2018
Estimated completion	25 October 2018
Sites	1 location across United States

Drugs / interventions tested

preservative free albuterol — full drug profile →

Conditions studied

Status Asthmaticus — all drugs for Status Asthmaticus →

Sponsor

Norton Healthcare — full company profile →

Who can join

Adults 5 to 17, any sex, with Status Asthmaticus. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed to compare the length of continuous albuterol administration between two different albuterol formulations, BAC containing albuterol versus preservative free albuterol.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Status Asthmaticus

Currently open trials in the same condition.

NCT05819541 — Treating Exacerbations of Asthma With Oral Montelukast in Children · Phase 2 · recruiting

Other Norton Healthcare trials

Trials by the same sponsor.

NCT04900285 — Pilot Study for Feasibility of Using an Oral Appliance for Decreasing Snoring · NA · unknown
NCT04366336 — BFRT vs Standard PT After Total Knee Arthroplasty · NA · withdrawn
NCT04364867 — Exparel for Total Shoulder Arthroplasty · Phase 4 · completed
NCT02819479 — Low-dose Intra-arterial Bevacizumab for Edema and Radiation Necrosis Therapeutic Intervention (LIBERTI) · Phase 2 · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02966184 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norton Healthcare
Last refreshed: 20 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02966184.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing